ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure
Status:
Terminated
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to see if the experimental drug ZP120, when given with the
approved drug furosemide to patients with acute or sub-acute heart failure, can reduce the
amount of fluid in the patients' lungs and make breathing easier.